
Inhibiting miR-182-3p Alleviates Gestational Diabetes Mellitus by Improving Insulin Resistance in Skeletal Muscle
Author(s) -
J. Subba Rao,
Youfang Chen,
Jing-Ying Huang,
Ruoying Wu,
Zhenzhu Dong,
Yuchen Gao,
Xuan Cheng
Publication year - 2021
Publication title -
balkan medical journal/balkan medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.398
H-Index - 16
eISSN - 2146-3131
pISSN - 2146-3123
DOI - 10.4274/balkanmedj.galenos.2021.2021-8-140
Subject(s) - glut4 , gestational diabetes , insulin resistance , endocrinology , medicine , insulin , microrna , glucose transporter , glucose uptake , carbohydrate metabolism , biology , pregnancy , gene , gestation , biochemistry , genetics
Gestational diabetes mellitus (GDM) is one of the most common metabolic diseases occurring during pregnancy. MiR-182-3p participates in a variety of physiological processes such as cell proliferation, apoptosis, differentiation, and migration5, but its role in GDM is largely unknown.